Bright Minds Biosciences, Inc. (DRUG)
20.75
+1.79
(+9.44%)
USD |
NASDAQ |
Nov 05, 16:00
20.76
+0.01
(+0.05%)
After-Hours: 20:00
Bright Minds Biosciences Price to Book Value : 0.9435 for Nov. 5, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 04, 2026 | 0.8621 |
| November 03, 2026 | 0.9798 |
| November 02, 2026 | 1.191 |
| October 30, 2026 | 2.500 |
| October 29, 2026 | 2.578 |
| October 28, 2026 | 2.515 |
| October 27, 2026 | 2.456 |
| October 26, 2026 | 2.323 |
| October 23, 2026 | 2.386 |
| October 22, 2026 | 2.396 |
| October 21, 2026 | 2.293 |
| October 20, 2026 | 2.510 |
| October 19, 2026 | 2.447 |
| October 16, 2026 | 2.332 |
| October 15, 2026 | 2.465 |
| October 14, 2026 | 2.306 |
| October 13, 2026 | 2.335 |
| October 12, 2026 | 2.456 |
| October 09, 2026 | 2.458 |
| October 08, 2026 | 2.364 |
| October 07, 2026 | 2.364 |
| October 06, 2026 | 2.194 |
| October 05, 2026 | 2.264 |
| October 02, 2026 | 2.305 |
| October 01, 2026 | 2.238 |
| Date | Value |
|---|---|
| September 30, 2026 | 2.265 |
| September 29, 2026 | 2.262 |
| September 28, 2026 | 2.349 |
| September 25, 2026 | 2.355 |
| September 24, 2026 | 2.433 |
| September 23, 2026 | 2.634 |
| September 22, 2026 | 2.758 |
| September 21, 2026 | 2.704 |
| September 18, 2026 | 2.773 |
| September 17, 2026 | 2.799 |
| September 16, 2026 | 2.688 |
| September 15, 2026 | 2.738 |
| September 14, 2026 | 2.882 |
| September 11, 2026 | 2.873 |
| September 10, 2026 | 2.955 |
| September 09, 2026 | 2.958 |
| September 08, 2026 | 3.042 |
| September 04, 2026 | 2.963 |
| September 03, 2026 | 3.093 |
| September 02, 2026 | 3.234 |
| September 01, 2026 | 3.221 |
| August 31, 2026 | 3.261 |
| August 28, 2026 | 3.310 |
| August 27, 2026 | 3.389 |
| August 26, 2026 | 3.484 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Amgen, Inc. | 17.35 |
| Lineage Cell Therapeutics, Inc. | 4.079 |
| Recursion Pharmaceuticals, Inc. | 2.162 |
| Agenus, Inc. | -- |
| Anika Therapeutics, Inc. | 1.881 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0828 |
| Price | 20.75 |
| Earnings Yield | -10.04% |
| Market Cap | 204.68M |
| PEGY Ratio | -0.0828 |